Cargando…

Immune Response Against SARS-CoV-2 Infection and Vaccination in a CD8α-Deficient Patient

Detalles Bibliográficos
Autores principales:	Arroyo-Sánchez, Daniel, Luczkowiak, Joanna, Delgado, Rafael, Cabrera-Marante, Oscar, Paz-Artal, Estela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160709/ https://www.ncbi.nlm.nih.gov/pubmed/37145391 http://dx.doi.org/10.1007/s10875-023-01497-5

Ejemplares similares

Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2022)

Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency
por: Arroyo-Sánchez, Daniel, et al.
Publicado: (2021)

Defending against SARS-CoV-2: The T cell perspective
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2023)

Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome
por: Pleguezuelo, Daniel E., et al.
Publicado: (2021)

Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19
por: Folgueira, Maria Dolores, et al.
Publicado: (2021)

The Weight of IgA Anti-β2glycoprotein I in the Antiphospholipid Syndrome Pathogenesis: Closing the Gap of Seronegative Antiphospholipid Syndrome
por: Cabrera-Marante, Oscar, et al.
Publicado: (2020)

Neutralizing Response Against SARS-CoV-2 Variants 8 Months After BNT162b2 Vaccination in Naive and COVID-19–Convalescent Individuals
por: Luczkowiak, Joanna, et al.
Publicado: (2021)

Incidence of thromboembolic events in asymptomatic carriers of IgA anti ß2 glycoprotein-I antibodies
por: Tortosa, Carlos, et al.
Publicado: (2017)

T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression
por: Gil-Etayo, Francisco Javier, et al.
Publicado: (2021)

The role of DC-SIGN as a trans-receptor in infection by MERS-CoV
por: Labiod, Nuria, et al.
Publicado: (2023)

Full efficacy and long-term immunogenicity induced by the SARS-CoV-2 vaccine candidate MVA-CoV2-S in mice
por: Lázaro-Frías, Adrián, et al.
Publicado: (2022)

A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection
por: Pérez, Patricia, et al.
Publicado: (2022)

An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution
por: Gil-Etayo, Francisco Javier, et al.
Publicado: (2022)

Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection
por: Pérez, Patricia, et al.
Publicado: (2022)

Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 Evolution
por: Garcinuño, Sara, et al.
Publicado: (2022)

Seroprevalence analysis of SARS-CoV-2 in pregnant women along the first pandemic outbreak and perinatal outcome
por: Villalaín, Cecilia, et al.
Publicado: (2020)

Development of Cd8α/α and Cd8α/β T Cells in Major Histocompatibility Complex Class I–Deficient Mice
por: Das, Gobardhan, et al.
Publicado: (1999)

Broad Neutralizing Activity Against Ebolaviruses Lacking the Mucin-Like Domain in Convalescent Plasma Specimens From Patients With Ebola Virus Disease
por: Luczkowiak, Joanna, et al.
Publicado: (2018)

Prime-Boost Vaccination With BNT162b2 Induces High Neutralizing Activity Against SARS-CoV-2 Variants in Naïve and COVID-19-Convalescent Individuals
por: Luczkowiak, Joanna, et al.
Publicado: (2021)

Perforin gene variant A91V in young patients with severe COVID-19
por: Cabrera-Marante, Oscar, et al.
Publicado: (2020)

Cross neutralization of SARS‐CoV‐2 omicron subvariants after repeated doses of COVID‐19 mRNA vaccines
por: Luczkowiak, Joanna, et al.
Publicado: (2022)

DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist
por: Thépaut, Michel, et al.
Publicado: (2021)

Decreased breadth of the antibody response to the spike protein of SARS-CoV-2 after repeated vaccination
por: Horndler, Lydia, et al.
Publicado: (2023)

Potent Neutralizing Activity of Polyclonal Equine Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern
por: Luczkowiak, Joanna, et al.
Publicado: (2022)

No Xenotropic Murine Leukemia Virus–related Virus Detected in Fibromyalgia Patients
por: Luczkowiak, Joanna, et al.
Publicado: (2011)

SARS-CoV-2-specific T-cell responses after COVID-19 recovery in patients with rheumatic diseases on immunosuppressive therapy
por: Lledó, Ana, et al.
Publicado: (2021)

Erratum: Virus-like glycodendrinanoparticles displaying quasi-equivalent nested polyvalency upon glycoprotein platforms potently block viral infection
por: Ribeiro-Viana, Renato, et al.
Publicado: (2013)

Virus-like glycodendrinanoparticles displaying quasi-equivalent nested polyvalency upon glycoprotein platforms potently block viral infection
por: Ribeiro-Viana, Renato, et al.
Publicado: (2012)

Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management
por: López-Nevado, Marta, et al.
Publicado: (2021)

Cell-mediated and Neutralizing Antibody Responses to the SARS-CoV-2 Omicron BA.4/BA.5–adapted Bivalent Vaccine Booster in Kidney and Liver Transplant Recipients
por: Fernández-Ruiz, Mario, et al.
Publicado: (2023)

CD8 T Cells Contribute to Vaccine Protection Against SARS-CoV-2 in Macaques
por: Liu, Jinyan, et al.
Publicado: (2022)

Shared CD8(+) T cell receptors for SARS-CoV-2
por: Levantovsky, Rachel, et al.
Publicado: (2020)

CD8(+) T-Cell Epitope Variations Suggest a Potential Antigen HLA-A2 Binding Deficiency for Spike Protein of SARS-CoV-2
por: Qiu, Congling, et al.
Publicado: (2022)

Tolerogenic Role of Myeloid Suppressor Cells in Organ Transplantation
por: Ochando, Jordi, et al.
Publicado: (2019)

Landscapes of SARS-CoV-2-reactive CD8(+) T cells: heterogeneity of host immune responses against SARS-CoV-2
por: Koh, June-Young, et al.
Publicado: (2021)

SARS-CoV-2-Specific and Functional Cytotoxic CD8 Cells in Primary Antibody Deficiency: Natural Infection and Response to Vaccine
por: Gupta, Sudhir, et al.
Publicado: (2022)

Expansion of an Unusual Virtual Memory CD8(+) Subpopulation Bearing Vα3.2 TCR in Themis-Deficient Mice
por: Prasad, Mukul, et al.
Publicado: (2021)

Identification of promising CD8 and CD4 T cell epitopes for peptide vaccine formulation against SARS-CoV-2
por: Chakraborty, Supriyo, et al.
Publicado: (2022)

CD8(+) T cells remember same bits of SARS-CoV-2
por: Mazet, Julie M., et al.
Publicado: (2020)

IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection
por: Villegas, Carolina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7v8ofu55hgt2vlriq18mdge3nd